the value of the platform seems to be in finding variables in the trial design they can change to increase the probability of success.
given the exorbitant cost in time and money of trials and the very high failure rates I would think pharma companies could be greatly interested in this type of technology
- Forums
- ASX - By Stock
- Ann: Pause in Trading
the value of the platform seems to be in finding variables in...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.902M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9516 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 4000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9516 | 0.017 |
2 | 221499 | 0.014 |
1 | 150000 | 0.013 |
2 | 390000 | 0.011 |
1 | 1000000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 4000 | 1 |
0.025 | 40003 | 1 |
0.030 | 500000 | 1 |
0.032 | 105961 | 1 |
0.033 | 233333 | 1 |
Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
Featured News
OPL (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online